Safety, tolerability, and pharmacokinetics of anti-EGFRvIII antibody–drug conjugate AMG 595 in patients with recurrent malignant glioma expressing EGFRvIII
Titel:
Safety, tolerability, and pharmacokinetics of anti-EGFRvIII antibody–drug conjugate AMG 595 in patients with recurrent malignant glioma expressing EGFRvIII
Auteur:
Rosenthal, Mark Curry, Richard Reardon, David A. Rasmussen, Erik Upreti, Vijay V. Damore, Michael A. Henary, Haby A. Hill, John S. Cloughesy, Timothy